These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

992 related items for PubMed ID: 10824239

  • 41. Clinical risk indices, prediction of osteoporosis, and prevention of fractures: diagnostic consequences and costs.
    Pongchaiyakul C, Nguyen ND, Eisman JA, Nguyen TV.
    Osteoporos Int; 2005 Nov; 16(11):1444-50. PubMed ID: 16170443
    [Abstract] [Full Text] [Related]

  • 42. Hand ultrasound for osteoporosis screening in postmenopausal women.
    Benitez CL, Schneider DL, Barrett-Connor E, Sartoris DJ.
    Osteoporos Int; 2000 Nov; 11(3):203-10. PubMed ID: 10824235
    [Abstract] [Full Text] [Related]

  • 43. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density.
    Schneider DL, Barrett-Connor EL.
    Arch Intern Med; 1997 Jun 09; 157(11):1241-5. PubMed ID: 9183236
    [Abstract] [Full Text] [Related]

  • 44. Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis.
    Campbell MS, Lichtenstein GR, Rhim AD, Pazianas M, Faust T.
    Liver Int; 2005 Apr 09; 25(2):311-6. PubMed ID: 15780055
    [Abstract] [Full Text] [Related]

  • 45. Performance of risk indices for identifying low bone density in postmenopausal women.
    Geusens P, Hochberg MC, van der Voort DJ, Pols H, van der Klift M, Siris E, Melton ME, Turpin J, Byrnes C, Ross P.
    Mayo Clin Proc; 2002 Jul 09; 77(7):629-37. PubMed ID: 12108600
    [Abstract] [Full Text] [Related]

  • 46. Differential effect of predictors of bone mineral density and hip geometry in postmenopausal women: a cross-sectional study.
    Singh R, Gupta S, Awasthi A.
    Arch Osteoporos; 2015 Jul 09; 10():39. PubMed ID: 26556785
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Diagnosis of low bone mass in CKD-5D patients.
    Blomquist GA, Davenport DL, Mawad HW, Monier-Faugere MC, Malluche HH.
    Clin Nephrol; 2016 Feb 09; 85(2):77-83. PubMed ID: 26587778
    [Abstract] [Full Text] [Related]

  • 49. Association between risk factors and bone mineral density and the development of a self-assessment tool for early osteoporosis screening in postmenopausal women with type 2 diabetes.
    Chen X, Jia X, Lan J, Wu W, Ni X, Wei Y, Zheng X, Liu J.
    PeerJ; 2024 Feb 09; 12():e18283. PubMed ID: 39403190
    [Abstract] [Full Text] [Related]

  • 50. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.
    Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM.
    JAMA; 2001 Dec 12; 286(22):2815-22. PubMed ID: 11735756
    [Abstract] [Full Text] [Related]

  • 51. Low bone mineral density is associated with breast cancer in postmenopausal women: a case-control study.
    Ferreira Poloni P, Vespoli HL, Almeida-Filho BS, Bueloni-Dias F, Nahas-Neto J, Nahas EAP.
    Climacteric; 2017 Oct 12; 20(5):491-497. PubMed ID: 28569124
    [Abstract] [Full Text] [Related]

  • 52. Plasma leptin concentrations in postmenopausal women with osteoporosis.
    Yilmazi M, Keleş I, Aydin G, Orkun S, Bayram M, Sevinc FC, Kisa U, Yetkin I.
    Endocr Res; 2005 Oct 12; 31(2):133-8. PubMed ID: 16353671
    [Abstract] [Full Text] [Related]

  • 53. Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women.
    Mueller D, Gandjour A.
    Value Health; 2009 Oct 12; 12(8):1106-17. PubMed ID: 19706151
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. A non-invasive prevention program model for the assessment of osteoporosis in the early postmenopausal period: a pilot study on FRAX(®) and QUS tools advantages.
    Villa P, Lassandro AP, Moruzzi MC, Amar ID, Vacca L, Di Nardo F, De Waure C, Pontecorvi A, Scambia G.
    J Endocrinol Invest; 2016 Feb 12; 39(2):191-8. PubMed ID: 26141076
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Habitual tea drinking and bone mineral density in postmenopausal Turkish women: investigation of prevalence of postmenopausal osteoporosis in Turkey (IPPOT Study).
    Hamdi Kara I, Aydin S, Gemalmaz A, Aktürk Z, Yaman H, Bozdemir N, Kurdak H, Sitmapinar K, Devran Sencar I, Başak O, Akdeniz M, Işildar H, Burgut E, Ozcan S, Akça U, Dağdeviren N, Ungan M.
    Int J Vitam Nutr Res; 2007 Nov 12; 77(6):389-97. PubMed ID: 18622949
    [Abstract] [Full Text] [Related]

  • 58. Osteoporosis in postmenopausal Saudi women using dual x-ray bone densitometry.
    El-Desouki MI.
    Saudi Med J; 2003 Sep 12; 24(9):953-6. PubMed ID: 12973476
    [Abstract] [Full Text] [Related]

  • 59. Pulse-echo ultrasound method for detection of post-menopausal women with osteoporotic BMD.
    Karjalainen JP, Riekkinen O, Kröger H.
    Osteoporos Int; 2018 May 12; 29(5):1193-1199. PubMed ID: 29460101
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.